177 related articles for article (PubMed ID: 12161492)
1. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.
Boscaro M; Sonino N; Scarda A; Barzon L; Fallo F; Sartori MT; Patrassi GM; Girolami A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3662-6. PubMed ID: 12161492
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy in Cushing's syndrome.
Trementino L; Arnaldi G; Appolloni G; Daidone V; Scaroni C; Casonato A; Boscaro M
Neuroendocrinology; 2010; 92 Suppl 1():55-9. PubMed ID: 20829619
[TBL] [Abstract][Full Text] [Related]
3. Clotting changes in Cushing's syndrome: elevated factor VIII activity.
Dal Bo Zanon R; Fornasiero L; Boscaro M; Ruffato G; Luzzato G; Fabris F; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):268-77. PubMed ID: 6194060
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic complications in Cushing's syndrome.
Small M; Lowe GD; Forbes CD; Thomson JA
Clin Endocrinol (Oxf); 1983 Oct; 19(4):503-11. PubMed ID: 6627701
[TBL] [Abstract][Full Text] [Related]
5. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state.
Dal Bo Zanon R; Fornasiero L; Boscaro M; Cappellato G; Fabris F; Girolami A
Thromb Haemost; 1982 Apr; 47(2):116-7. PubMed ID: 6808692
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of glucocorticoids: coagulopathy.
Coelho MC; Santos CV; Vieira Neto L; Gadelha MR
Eur J Endocrinol; 2015 Oct; 173(4):M11-21. PubMed ID: 25971647
[TBL] [Abstract][Full Text] [Related]
7. Incidence and late prognosis of cushing's syndrome: a population-based study.
Lindholm J; Juul S; Jørgensen JO; Astrup J; Bjerre P; Feldt-Rasmussen U; Hagen C; Jørgensen J; Kosteljanetz M; Kristensen L; Laurberg P; Schmidt K; Weeke J
J Clin Endocrinol Metab; 2001 Jan; 86(1):117-23. PubMed ID: 11231987
[TBL] [Abstract][Full Text] [Related]
8. Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?
Barbot M; Daidone V; Zilio M; Albiger N; Mazzai L; Sartori MT; Frigo AC; Scanarini M; Denaro L; Boscaro M; Casonato S; Ceccato F; Scaroni C
Pituitary; 2015 Aug; 18(4):487-93. PubMed ID: 25239557
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of vascular complications in Cushing's syndrome.
Miljic P; Miljic D; Cain JW; Korbonits M; Popovic V
Hormones (Athens); 2012; 11(1):21-30. PubMed ID: 22450342
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome.
Sjöberg HE; Blombäck M; Granberg PO
Acta Med Scand; 1976; 199(1-2):95-8. PubMed ID: 1251777
[TBL] [Abstract][Full Text] [Related]
11. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
[TBL] [Abstract][Full Text] [Related]
12. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
Kastelan D; Dusek T; Kraljevic I; Polasek O; Giljevic Z; Solak M; Salek SZ; Jelcic J; Aganovic I; Korsic M
Endocrine; 2009 Aug; 36(1):70-4. PubMed ID: 19381886
[TBL] [Abstract][Full Text] [Related]
13. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
[TBL] [Abstract][Full Text] [Related]
14. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
[TBL] [Abstract][Full Text] [Related]
16. The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome.
Swiatkowska-Stodulska R; Kaniuka-Jakubowska S; Wisniewski P; Skibowska-Bielinska A; Sworczak K
Eur J Endocrinol; 2011 Dec; 165(6):865-71. PubMed ID: 21914670
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis).
Kaulitz R; Ziemer G; Rauch R; Girisch M; Bertram H; Wessel A; Hofbeck M
J Thorac Cardiovasc Surg; 2005 Mar; 129(3):569-75. PubMed ID: 15746740
[TBL] [Abstract][Full Text] [Related]
18. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.
Bochicchio D; Losa M; Buchfelder M
J Clin Endocrinol Metab; 1995 Nov; 80(11):3114-20. PubMed ID: 7593411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
